Methyl (S)-2-(Boc-amino) -3-[(S) -2-oxo-3-pyrrolidinyl] propanoate CAS 328086-60-8 PF-07321332 Boceprevir Intermediate
Samar da Kasuwanci PF-07321332 Matsakaici masu alaƙa da Paxlovid tare da Babban inganci
L-tert-Leucine (H-Tle-OH) CAS 20859-02-3
Caronic Anhydride CAS 67911-21-1
(1R,2S,5S)-6,6-Dimethyl-3-azabicyclo[3.1.0]hexane-2-Carboxylic Acid Methyl Ester Hydrochloride 565456-77-1
Methyl (S)-2-(Boc-amino) -3-[(S) -2-oxo-3-pyrrolidinyl] propanoate CAS 328086-60-8
6,6-Dimethyl-3-azabicyclo[3.1.0] hexane CAS 943516-54-9
Sunan Sinadari | Methyl (S)-2-(Boc-amino)-3-[(S) -2-oxo-3-pyrrolidinyl] propanoate |
Makamantu | Methyl (S)-2-((tert-butoxycarbonyl)amino) -3-((S) -2-oxopyrrolidin-3-yl) propanoate;(αS,3S) -α- [(tert-Butyloxycarbonyl) aMino] -2-oxo-3-pyrrolidinepropanoic acid Methyl Ester;(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-((S)-2-oxopyrrolidin-3-yl) propanoate |
Lambar CAS | 328086-60-8 |
Lambar CAT | Saukewa: RF-PI317 |
Matsayin Hannun jari | A Hannun jari, Ma'aunin Samfuran Har zuwa Daruruwan Kilogram |
Tsarin kwayoyin halitta | Saukewa: C13H22N2O5 |
Nauyin Kwayoyin Halitta | 286.33 |
Alamar | Ruifu Chemical |
Abu | Ƙayyadaddun bayanai |
Bayyanar | Fari zuwa Kashe-Farin Foda |
Identification A | IR: Mai kama da Abun Magana |
Identity B | Lokacin Tsayawa: Kama da Abun Magana |
Asara akan bushewa | ≤1.0% |
Ragowa akan Ignition | ≤0.20% |
Tsaftace Guda Daya | ≤0.50% |
Jimlar ƙazanta | ≤2.0% |
Karfe masu nauyi (Pb) | ≤20ppm |
Tsafta | ≥98.0% |
Matsayin Gwaji | Matsayin Kasuwanci |
Amfani | Matsakaicin PF-07321332 Paxlovid (CAS 2628280-40-8) da Boceprevir (CAS 394730-60-0) |
Kunshin: Bottle, Aluminum tsare jakar, Kwali drum, 25kg / Drum, ko bisa ga abokin ciniki ta bukata.
Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske, danshi da kamuwa da kwari.
Methyl (S) -2- (Boc-amino) -3- [(S) -2-oxo-3-pyrrolidinyl] propanoate (CAS 328086-60-8) shine matsakaici na PF-07321332 Paxlovid (CAS 2628280-40) -8) da Boceprevir (CAS 394730-60-0).PF-07321332, babban ɓangaren Paxlovid (PF-07321332 da Ritonavir) wanda shine ɗan takarar bincike na COVID-19 na baka, shine mai hana 3C-kamar protease (3CLPRO) na baki tare da tasirin antiviral akan kwayar cutar SARS-CoV-2. da COVID-19.A ranar 6 ga Nuwamba, 2021, Pfizer ya ba da sanarwar cewa Paxlovid ya ragu sosai a asibiti da mutuwa, bisa ga wani bincike na wucin gadi na Mataki na 2/3 EPIC-HR (Kimanin Hana Protease don COVID-19 a cikin Marasa Lafiya Masu Haɗari) bazuwar, binciken makafi biyu. na manya marasa lafiya marasa asibiti tare da COVID-19, waɗanda ke cikin haɗarin ci gaba zuwa rashin lafiya mai tsanani.Boceprevir (EBP-520) shine mai hana HCV protease inhibitor (Ki=14 nM) don maganin kamuwa da cutar hanta.Boceprevir tare da pegylated interferon da ribavirin (PegIFN/RBV) sun ba da damar haɓakawa a cikin ƙimar amsawar ƙwayoyin cuta na marasa lafiya tare da genotype 1 HCV.Boceprevir yana hulɗa tare da maganin rigakafi (IT) ta hanyar hana cytochrome P450 3A enzyme.